Table 1.
Baseline Demographic, Clinical, and Laboratory Characteristics of the Study Groups
| Patients, n = 138 | Controls, n = 121 | P | |
|---|---|---|---|
| Age, y | 41.6 ± 3.0 | 41.9 ± 3.3 | 0.20 |
| Gender | |||
| Male, n (%) | 100 (72.5) | 78 (64.5) | 0.17 |
| Female, n (%) | 38 (27.5) | 43 (35.5) | |
| BMI, kg/m2 | 30.03 ± 4.84 | 28.78 ± 3.95 | 0.10 |
| Family history, n (%) | 54 (39.1) | 57 (47.1) | 0.20 |
| Smoking, n (%) | 98 (71.4) | 38 (31.4) | 0.01 |
| Diabetes mellitus, n (%) | 32 (23.2) | 15 (12.4) | 0.02 |
| Hypertension, n (%) | 56 (40.6) | 32 (26.4) | 0.02 |
| Hyperlipidemia, n (%) | 58 (42) | 30 (24.8) | 0.01 |
| CCTA findings | |||
| No. of diseased vessels | 1.7 ± 0.8 | — | — |
| No. of plaques | 2.1 ± 1.4 | — | — |
| Distribution of plaques | |||
| Calcified type | 0.8 ± 0.5 | — | — |
| Noncalcified type | 1.2 ± 1.0 | — | — |
| Mixed type | 0.7 ± 0.4 | — | — |
| Laboratory findings | |||
| Creatinine, mg/dL | 0.71 ± 0.13 | 0.68 ± 0.16 | 0.01 |
| Total cholesterol, mg/dL | 216.5 ± 43.5 | 200.2 ± 39.3 | 0.01 |
| LDL‐cholesterol, mg/dL | 144.6 ± 40.6 | 129.8 ± 35.1 | 0.01 |
| HDL‐cholesterol, mg/dL | 34.8 ± 6.6 | 44.2 ± 11.6 | 0.01 |
| Triglyceride | 187.6 ± 123.6 | 140.8 ± 90.1 | 0.01 |
| Uric acid, mg/dL | 5.8 ± 1.2 | 4.7 ± 1.07 | 0.01 |
| HbA1c, % | 6.2 ± 1.3 | 5.8 ± 0.6 | 0.01 |
| hs‐CRP, mg/dL | 1.78 ± 0.72 | 1.04 ± 0.51 | 0.01 |
| GGT, U/L | 35.7 ± 14.7 | 19.6 ± 10.0 | 0.01 |
Abbreviations: BMI, body mass index; CCTA, coronary computed tomography angiography; GGT, gamma‐glutamyl transferase; HbA1c, hemoglobin A1c; HDL, high‐density lipoprotein; hs‐CRP, high‐sensitivity C‐reactive protein; LDL, low‐density lipoprotein.
Values are presented as means ± standard deviation or number (%), as appropriate.